MYX
Click for more information
0.00% $3.88 mayne pharma group limited

Mithra’s Donesta phase 3 trial results

  1. flyer100
    352 Posts.
    lightbulb Created with Sketch. 201
    clock Created with Sketch.
    18/10/22
    12:37
    Post #: 64254150
    Mithra released their stage 3 efficacy trials a couple of days ago regarding menopausal treatments.
    The results were outstanding.
    I can’t see how rulers are not being run over these companies given MYX cash position and Mithra’s
    focus on womens health.

    It’s just a matter of time IMO before we see something between these two entities.
    MYX Price at posting: 28.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$3.88 		Change
0.000(0.00%) 		Mkt cap ! $330.0M
Open High Low Value Volume
$3.89 $3.94 $3.87 $178.6K 45.81K

Buyers (Bids)

No. Vol. Price($)
1 587 $3.88
 

Sellers (Offers)

Price($) Vol. No.
$3.90 137 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.